- cross-posted to:
- pharma@lemmy.world
- cross-posted to:
- pharma@lemmy.world
Now, the drugmaker said it expects all of its Bicillin L-A (penicillin G benzathine injectable suspension) pediatric (600,000 units/mL) prefilled syringes will be unavailable in mid-2023, and all Bicillin C-R (penicillin G benzathine and penicillin G procaine injectable suspension) solutions will “deplete” in the third quarter of 2023.
You must log in or register to comment.